Fate Therapeutics
(FATE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 133,583 | 129,180 | 76,654 | 106,413 | 167,347 |
| Marketable Securities | 482,327 | 549,521 | 618,942 | 683,722 | 315,569 |
| Receivables | 8,676 | 7,311 | 10,303 | 6,945 | 5,515 |
| TOTAL | $633,412 | $693,713 | $713,268 | $804,316 | $494,323 |
| Non-Current Assets | |||||
| PPE Net | 91,529 | 74,617 | 59,213 | 47,950 | 32,308 |
| Investments And Advances | 100,664 | 124,877 | 149,501 | 98,284 | 0 |
| Other Non-Current Assets | 95,850 | 91,364 | 93,684 | 95,414 | 95,826 |
| TOTAL | $288,043 | $290,858 | $302,398 | $241,648 | $128,134 |
| Total Assets | $921,455 | $984,571 | $1,015,666 | $1,045,964 | $622,457 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,612 | 6,439 | 5,771 | 8,998 | 6,283 |
| Accrued Expenses | 42,412 | 54,003 | 25,736 | 20,931 | 15,564 |
| Other current liabilities | 3,200 | 3,200 | 45,993 | 39,203 | 39,218 |
| TOTAL | $81,284 | $91,884 | $105,600 | $94,577 | $85,564 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 21,483 | 23,545 | 23,032 | 21,033 | 21,144 |
| Other Non-Current Liabilities | 134,209 | 129,792 | 119,070 | 118,267 | 106,427 |
| TOTAL | $161,333 | $162,355 | $157,995 | $161,292 | $152,448 |
| Total Liabilities | $242,617 | $254,239 | $263,595 | $255,869 | $238,012 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 96,428 | 95,493 | 95,185 | 94,036 | 93,783 |
| Common Shares | 96 | 95 | 94 | 94 | 88 |
| Retained earnings | -769,083 | -700,462 | -657,154 | -602,021 | -556,932 |
| Other shareholders' equity | -759 | -70 | -83 | -257 | 73 |
| TOTAL | $678,838 | $730,332 | $752,071 | $790,095 | $384,445 |
| Total Liabilities And Equity | $921,455 | $984,571 | $1,015,666 | $1,045,964 | $622,457 |